Sponsored and produced by Focus Limited.
The Year Payers Stopped Threatening
Citing cherry-picked patients, unrealistic dosing, and placebo control, payers will increasingly require that the proof for payment of drugs must come from head-to-head trials.
Filling the Gaps
Heading the WHO list are pandemic influenza and antibiotic-resistant bacterial infections. Together the two could kill millions.
2 Commerce Drive Cranbury, NJ 08512